2Tanaka M ,Otsuki M ,Une T,et al. In vitro activity of DR-3355,an optically active isomer of ofloxacin. J Antimicrob chemother,1990,26:659
3Goa KL,Bryson HM,Markham A,et al Sparfloxacin. A review of its antibacterial activity, phamacokinetic properties,clinical efficacy and tolerability in lower respiratory tract infections. Drugs,1997,53:700
4Ball P, Tillotson G. Tolerability of fluoroguinolone antibiotics.Past, present and future, Drug saf, 1995,13: 343
5Hughes S. Withdrawals without widespread disnster Scrip Magazine,2000,Feb, 66
6Woodcock JM,Andrews JM,Boswell FJ,et al. In vitro activity of Bay 12-8039, a new fluoroguinolone. Antimicrob Agents chemother, 1997,41:101
7Stass HH, Dalhoff D, Kubitza D, Bay 12-8039. A new 8-methoxyguinulone:first phamacokinetic (PK) results in health male volunteers. Morial EN,ed. The 36th Interscience congross for Antimicrobial Agents and chemotherapy. New Orleans. 1996,Abstract 104 (F-024)
